Site Search
Company Search
Get Quote
"The QualityStocks Daily", our free summary formatted newsletter containing stock tips from hundreds of online investment newsletters.
QualityStocksNewsBreaks
- 1:42 pm QualityStocksNewsBreaks – Astiva Health Is Redefining Senior Healthcare
- 1:39 pm QualityStocksNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Addresses Proceedings Initiated by Dominion
- 11:16 am QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Enters Into Private Placement Agreements to Raise Funds for Development of AVERSA Fentanyl
QualityStocksSpotlight Company
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN)
Investment Considerations Cybin Inc. currently has three molecules in development with four sponsored clinical trials planned for 2022 and a preclinical pipeline of 50+ novel assets. The company’s management team is composed of leaders with experience in various aspects of the pharmaceutical and innovative therapeutics market and is further supported by external partnerships with world-class … Continue reading “Cybin Inc. (NYSE American: CYBN) (NEO: CYBN)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
Interested in a live, online demonstration?
Get a walkthrough of our products and services.
- Recognize the difference of our innovative, all-encompassing approach
- See how we will drive results for your company
- Understand the power of our partnerships to extend your reach and recognition in the investment community and beyond
